Literature DB >> 20044053

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes.

Andreas Brave1, Ulrika Johansson, David Hallengärd, Shirin Heidari, Hanna Gullberg, Britta Wahren, Jorma Hinkula, Anna-Lena Spetz.   

Abstract

Delivery of DNA encoding foreign antigens into mammalian cells can induce adaptive immune responses. There are currently many DNA-based vaccines in clinical trials against infectious diseases and cancer but there is a lack of adjuvants for improvement of responses to DNA-based vaccines. Here, we show augmented systemic and mucosa-associated B cell responses after immunization with a cocktail of seven different plasmids (3 env, 2 gag, 1 rev, 1 RT) combined with mitogen activated apoptotic syngeneic lymphocytes in mice. In addition we show that apoptotic cells can function as adjuvant for induction of cellular immune responses in a magnitude comparable to the cytokine adjuvant GM-CSF in mice. These data suggest that activated apoptotic lymphocytes can act independent as adjuvants to improve antigen-specific DNA vaccines. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044053     DOI: 10.1016/j.vaccine.2009.12.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Activated apoptotic cells induce dendritic cell maturation via engagement of Toll-like receptor 4 (TLR4), dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), and β2 integrins.

Authors:  Sushil Kumar Pathak; Annette E Sköld; Venkatramanan Mohanram; Catrine Persson; Ulrika Johansson; Anna-Lena Spetz
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 2.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 3.  Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease.

Authors:  Geoffrey O Ouma; Rebecca A Jonas; M Haris U Usman; Emile R Mohler
Journal:  Vasc Med       Date:  2012-04-11       Impact factor: 3.239

4.  Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.

Authors:  Hannes Uchtenhagen; Torben Schiffner; Emma Bowles; Leo Heyndrickx; Celia LaBranche; Steven E Applequist; Marianne Jansson; Thushan De Silva; Jaap Willem Back; Adnane Achour; Gabriella Scarlatti; Anders Fomsgaard; David Montefiori; Guillaume Stewart-Jones; Anna-Lena Spetz
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

5.  Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination.

Authors:  Tina Falkeborn; Andreas Bråve; Marie Larsson; Britt Akerlind; Ulf Schröder; Jorma Hinkula
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

6.  Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques.

Authors:  Biliana Todorova; Lucille Adam; Slobodan Culina; Raphaël Boisgard; Frédéric Martinon; Antonio Cosma; Mart Ustav; Thierry Kortulewski; Roger Le Grand; Catherine Chapon
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 7.  Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives.

Authors:  Florian Simon; Mansur Duran; Waseem Garabet; Hubert Schelzig; Michael Jacobs; Alexander Gombert
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

8.  Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.

Authors:  Rémi Vernet; Emily Charrier; Erika Cosset; Sabine Fièvre; Ugo Tomasello; Julien Grogg; Nicolas Mach
Journal:  Vaccines (Basel)       Date:  2021-05-10

9.  HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Authors:  J Hinkula; S Petkov; K Ljungberg; D Hallengärd; A Bråve; M Isaguliants; T Falkeborn; S Sharma; V Liakina; M Robb; M Eller; B Moss; G Biberfeld; E Sandström; C Nilsson; K Markland; P Blomberg; B Wahren
Journal:  Heliyon       Date:  2017-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.